FanHouse Kirill Sidelnikov

Lost in the aftermath of Tim Sylvia's shocking nine-second knockout loss to Ray Mercer on Saturday night is how it may drastically affected Paul Buentello's summer plans. "The Headhunter" was scheduled to face Sylvia at "Affliction: Trilogy" on August, but is now unsure as to whether or not that fight will happen.

FanHouse spoke to Buentello on Sunday about his thoughts on Sylvia's loss and why he may now have to wait a little longer to face the former UFC heavyweight champion.

In January, the Russian MMA fighter Kirill Sidelnikov lost a fight with the American Paul Buentello at the Affliction: Day of Reckoning event in Anaheim. This week the California State Athletic Commission revealed that Sidelnikov tested positive for the steroid Stanazolol after the fight.

Even though the 20-year-old Sidelnikov isn't a big name in MMA, his positive test was big news in the MMA community, in part because Sidelnikov has a close relationship with the world's best MMA fighter, Fedor Emelianenko. Sidelnikov and Emelianenko train together, and Sidelnikov's nickname is "Baby Fedor."

Trying to quell the controversy surrounding Sidenlikov's positive test, on Wednesday his promoter, M-1 Global, released a statement saying that Sidelnikov took the steroids unknowingly, as a result of using a nasal spray given to him by a coach who was trying to help him recover from a broken nose.

UPDATE: Paul Buentello discusses Sidelnikov's positive test.

M-1 Global's full statement is below.

Welcome to the FanHouse live blog of tonight's Affliction: Day of Reckoning pay-per-view undercard, where we'll have live updates and round-by-round scoring of all the fights: Josh Barnett vs. Gilbert Yvel, Matt Lindland vs. Vitor Belfort, Renato Babalu Sobral vs. Rameau Thierry Sokoudjou, Kirill Sidelnikov vs. Paul Buentello, Jay Hieron vs. Jason High and Dan Lauzon vs. Bobby Green.

If you just want to know who won the fights and how, check out the Affliction results post. The pay-per-view show and the live blog have started below.